Clinical Trial Information
CARDEA- Category: COVID-19
- Status: Active
- Ends: Dec 31, 2022
Description of Trial:
A randomized, controlled open-label study of CM4620 injectable emulsion in patients with severe COVID-19 pneumonia.
I want to
Close
A randomized, controlled open-label study of CM4620 injectable emulsion in patients with severe COVID-19 pneumonia.
Study Purpose Heart Sense is conducting a no-cost research study to determine the prevalence of aortic valve disease in Baton Rouge and the surrounding communities. Participation Over the course of a 12-month period, heart screening events will be held at a variety of locations (participating physician offices, hospitals, ERs, etc.) and times for the convenience of ...
Continue ReadingEvaluation of treatment strategies for severe calcific coronary arteries: orbital atherectomy vs. conventional angioplasty technique prior to implantation of drug-eluting stents.
Continue ReadingA randomized phase iii clinical trial evaluating post-mastectomy chest wall and regional nodal xrt and post-lumpectomy regional nodal xrt in patients with positive axillary nodes before neoadjuvant chemotherapy who convert to pathologically negative axillary nodes after neoadjuvant chemotherapy. For other cancer and oncology clinical trials and research opportunities, visit: ...
Continue Reading